IBI303, a biosimilar to adalimumab, for the treatment of patients with ankylosing spondylitis in China: a randomised, double-blind, phase 3 equivalence trial
Resource Type
Article
Authors
Xu, Huji ; Li, Zhijun ; Wu, Jian ; Xing, Qian ; Shi, Guixiu ; Li, Juan ; Liu, Xu ; Wu, Lijun ; Li, Xiaomei ; Tan, Wenfeng ; He, Dongyi ; Bi, Liqi ; Li, Hongbin ; Xiao, Zhengyu ; Shuai, Zongwen ; Li, Xiaoxia ; Wang, Yongfu ; Luo, Li ; Zheng, Yi ; Xiao, Weiguo ; Wu, Xin ; Zhou, Ling ; Li, Ting ; Qian, Lei ; Zhou, Hui ; Lu, Shujie ; Zheng, Shirui ; Xiong, Yan ; Wang, Xiong ; Wang, Yanqi ; Wu, Xinjiang
Source
In The Lancet Rheumatology September 2019 1(1):e35-e43
Subject
Primary Research Articles
Language
ISSN
2665-9913